These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19560707)

  • 1. Regression of cardiac amyloid after autologous stem-cell transplantation.
    Blair JE; Zeigler SM; Mehta J; Singhal S; Cotts W
    J Heart Lung Transplant; 2009 Jul; 28(7):746-8. PubMed ID: 19560707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure.
    Maurer MS; Raina A; Hesdorffer C; Bijou R; Colombo P; Deng M; Drusin R; Haythe J; Horn E; Lee SH; Marboe C; Naka Y; Schulman L; Scully B; Shapiro P; Prager K; Radhakrishnan J; Restaino S; Mancini D
    Transplantation; 2007 Mar; 83(5):539-45. PubMed ID: 17353770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac amyloidosis: what are the indications for transplant?
    Bradshaw SH; Veinot JP
    Curr Opin Cardiol; 2012 Mar; 27(2):143-7. PubMed ID: 22314298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation.
    Reich G; Held T; Siegert W; Kampf D; Dörken B; Maschmeyer G
    Bone Marrow Transplant; 2001 Feb; 27(3):341-3. PubMed ID: 11277185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
    Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
    J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural analysis of amyloidoma.
    Garcia CA; Abell-Aleff PC; Gamb SI; Miller DV
    Ultrastruct Pathol; 2009; 33(3):123-7. PubMed ID: 19479652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies.
    Varr BC; Liedtke M; Arai S; Lafayette RA; Schrier SL; Witteles RM
    J Heart Lung Transplant; 2012 Mar; 31(3):325-31. PubMed ID: 22051505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent cardiac amyloidosis following previous heart transplantation.
    Luk A; Ahn E; Lee A; Ross HJ; Butany J
    Cardiovasc Pathol; 2010; 19(4):e129-33. PubMed ID: 19740680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
    Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T
    Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
    Leung N; Dispenzieri A; Lacy MQ; Kumar SK; Hayman SR; Fervenza FC; Cha SS; Gertz MA
    Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis.
    Mignot A; Bridoux F; Thierry A; Varnous S; Pujo M; Delcourt A; Gombert JM; Goujon JM; Favreau F; Touchard G; Herpin D; Jaccard A
    Haematologica; 2008 Mar; 93(3):e32-5. PubMed ID: 18310532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart transplantation for cardiac amyloidosis: successful one-year outcome despite recurrence of the disease.
    Conner R; Hosenpud JD; Norman DJ; Pantely GA; Cobanoglu A; Starr A
    J Heart Transplant; 1988; 7(2):165-7. PubMed ID: 3284989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current indications, strategies, and outcomes with cardiac transplantation for cardiac amyloidosis and sarcoidosis.
    Rosenbaum AN; Edwards BS
    Curr Opin Organ Transplant; 2015 Oct; 20(5):584-92. PubMed ID: 26262459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern treatment of amyloidosis: unresolved questions.
    Dember LM
    J Am Soc Nephrol; 2009 Mar; 20(3):469-72. PubMed ID: 19073820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring.
    Goldsmith YB; Liu J; Chou J; Hoffman J; Comenzo RL; Steingart RM
    Am J Cardiol; 2009 Oct; 104(7):990-4. PubMed ID: 19766769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of amyloidosis].
    Wien TN
    Tidsskr Nor Laegeforen; 2008 Jun; 128(12):1397-400. PubMed ID: 18552901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autologous stem cell transplantation in the treatment of primary systemic amyloidosis].
    Gil L; Komarnicki M
    Pol Merkur Lekarski; 2009 Sep; 27(159):181-4. PubMed ID: 19827724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence.
    Collins AB; Smith RN; Stone JR
    Cardiovasc Pathol; 2009; 18(4):205-16. PubMed ID: 18619857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in myocardial delayed enhancement after autologous stem cell transplant in a patient with light chain amyloidosis.
    Bonnichsen CR; Glockner JF; Grogan M
    Circ Heart Fail; 2012 May; 5(3):e55. PubMed ID: 22589368
    [No Abstract]   [Full Text] [Related]  

  • 20. AL amyloidosis manifesting as systemic lymphadenopathy.
    Matsuda M; Gono T; Shimojima Y; Yoshida T; Katoh N; Hoshii Y; Yamada T; Ikeda S
    Amyloid; 2008 Jun; 15(2):117-24. PubMed ID: 18484338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.